Blog

ReCARE SNA technology conquers the Brazilian public healthcare system

  • quinta, 04 de maio de 2023
  • ReCARE

Recare SNA is the world's leading Advanced Neuromuscular Electrical Stimulation technology for ICU, patented in Brazil, the European Union, and the United States for use and application in Intensive Care Units.

Our partner distributors and public agencies at all government levels have access to various modalities for sale or purchase, such as:

1- Inexigibility process - Art. 25 of Law 8666/93, a product recognized by the competent regulatory agency as an exclusive technology and with a certificate from entities such as Federations or Employer Confederation, responsible for composing and validating the dispensation process by article 25 of the National Bidding Law.

2- Bids from north to south in Brazil: The product is already standardized and has a code in Ebserh, thus we already have bids in Federal Hospitals nationwide.

3- Adhesion to Price Registration Table: we have valid price registration tables that can be used for adherence within the limit provided for by law.

4- Bids for outsourcing companies: there are bids for outsourcing labor for SUS (Brazilian public healthcare system), which already request in the reference term or can use Recare Technology for differentiation of technology in the technical approval of the winning bidder.

5- Bids for national States and Municipalities: We have several ongoing processes where we are the only company eligible to compete, since Recare is a patented technology and has no competitors.

6- Research project funding: University Hospitals can request technology for research and publication of scientific content through specific funding.

Currently, we have more than 15 ongoing research projects in Brazil and around the world with the technology that is revolutionizing ICUs and empowering healthcare professionals in the care of critical patients.

This December, we delivered several equipment for bidding on tenders, equipment for research, and also participated in new bidding processes for Federal Hospitals.

We had highlights in supplying Recare for research purposes in new hospitals such as Risoleta Tolentino Neves University Hospital of UFMG and finally, we also participated in tenders in relevant institutions in Brazil such as the Hospital Foundation of the State of Minas Gerais: FHEMIG.